IV drips or oral supplements — which is right?
The honest answer is that the question is usually the wrong one. What matters is whether a nutrient is actually low, and whether the digestive tract can absorb it. Once those two things are known, the route almost chooses itself: a working gut means tablets, and a failing one means an infusion.
Marketing for wellness infusions tends to frame the comparison as tablets versus drips, as though one were simply a stronger version of the other. Clinically, they are answers to two different situations. Oral supplementation corrects a shortfall gradually in someone whose absorption is intact. Intravenous treatment bypasses the digestive tract entirely, which is valuable precisely when the digestive tract is the problem — and largely redundant when it is not.
Where the evidence currently sits
The evidence base here is thinner than the marketing suggests. A CADTH review of intravenous multivitamin therapy searched 396 citations and found so little relevant trial data that it was unable to reach a conclusion, and identified no evidence-based guidelines. A 2025 review in Cureus similarly notes the absence of robust clinical evidence for wellness infusions in otherwise healthy people. Established use of the intravenous route rests on treating diagnosed deficiency and specific medical conditions — not on trial evidence of benefit in people whose nutritional status is normal.
Sources: Canadian Agency for Drugs and Technologies in Health — Intravenous Multivitamin Therapy Use in Hospital or Outpatient Settings: A Review of Clinical Effectiveness and Guidelines (NCBI Bookshelf); To IV or Not to IV: The Science Behind Intravenous Vitamin Therapy (review, Cureus 2025)
How does absorption actually work?
There is no single figure for how much of a supplement the body absorbs. Bioavailability differs by nutrient, by dose and by the person taking it. Several nutrients are absorbed through saturable transport systems, which means the percentage absorbed falls as the dose rises — not that absorption is poor at sensible doses.
Vitamin C is the clearest worked example. Controlled pharmacokinetic research in healthy volunteers found that a single 200 mg dose was completely bioavailable, while at single doses of 500 mg and above bioavailability declined and the surplus was excreted in urine. The limiting factor is the intestinal transporter, not the tablet. Taking a very large oral dose does not produce a proportionally large rise in plasma concentration — it mostly produces expensive urine.
Vitamin B12 behaves quite differently. Most dietary B12 is absorbed through a specific mechanism requiring intrinsic factor, a protein made in the stomach, and that pathway handles only a small quantity per dose. A separate, far less efficient passive route means that a small fraction of a very large oral dose crosses the gut wall regardless of intrinsic factor — which is why high-dose oral B12 can work for some people even when the usual mechanism is impaired, and why the choice between tablets and injections in B12 deficiency depends on the underlying cause rather than on a general rule about routes.
Iron is different again: absorption is regulated by the body according to its own stores and by inflammation, and it is affected by what else is in the stomach at the time. Three nutrients, three unrelated mechanisms. That is why blanket statements comparing 'oral absorption' with 'IV absorption' as though they were fixed numbers should be treated with caution.
Why the headline absorption figures do not hold up
Wellness marketing often contrasts a single fixed absorption percentage for the intravenous route with a much lower fixed percentage for anything swallowed. No such pair of numbers exists, because bioavailability varies by nutrient, by dose and by the individual — the comparison collapses unrelated mechanisms into one figure. It is also beside the point: getting a nutrient into the bloodstream faster does not by itself produce a health benefit in someone who was not deficient.
Sources: Levine M, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. PNAS 1996;93(8):3704-9; NIH Office of Dietary Supplements — Vitamin B12 Fact Sheet for Health Professionals; NIH Office of Dietary Supplements — Vitamin C Fact Sheet for Health Professionals
When are oral supplements genuinely sufficient?
For the large majority of people — those with a healthy digestive tract, no relevant surgery and no malabsorptive disease — oral supplementation is the appropriate way to correct a confirmed deficiency. It is slower, and that is usually irrelevant, because most nutritional deficiencies develop over months and can safely be corrected over months.
- A confirmed but mild or moderate deficiency in someone with normal gut function.
- Iron deficiency anaemia in most adults: oral iron is recommended as first-line treatment in national guidance, with intravenous iron reserved for defined situations.
- Dietary shortfalls linked to restricted eating patterns — for example vitamin B12 in a long-term vegan diet without fortified foods.
- Maintenance after a deficiency has already been corrected.
- Mild to moderate dehydration, where oral fluids are effective. A Cochrane review of children with gastroenteritis found no clinically important difference in outcomes between oral and intravenous rehydration, and concluded that oral rehydration should be first-line, with the intravenous route used if the oral route fails — which it did in roughly one child in 25.
It is also worth stating the least commercially appealing fact in this field: if blood tests are normal and diet is reasonable, the appropriate action is usually neither an infusion nor a supplement. Correcting something that is not low does not improve health, and some nutrients accumulate.
Sources: British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults (PMC); Cochrane Database of Systematic Reviews — Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children
When is an IV route genuinely indicated?
Intravenous administration earns its place when the digestive tract cannot do the job, when oral treatment has already failed or cannot be tolerated, or when a deficiency is severe enough that the speed of correction matters clinically. These are diagnoses, and they are made by a doctor after assessment and testing.
Malabsorption
Coeliac disease, inflammatory bowel disease and other conditions that damage or inflame the intestinal lining can prevent adequate absorption regardless of the oral dose taken.
After bariatric or bowel surgery
Procedures that remove or bypass parts of the stomach or small intestine alter the anatomy absorption depends on. Long-term nutrient monitoring and, in some cases, parenteral replacement are part of standard follow-up.
Pernicious anaemia
An autoimmune loss of intrinsic factor. NHS guidance describes treatment with hydroxocobalamin injections, initially as a loading course and then as lifelong maintenance, because the underlying malabsorption cannot be corrected.
Iron deficiency needing the IV route
Intravenous iron is used where oral iron is not tolerated after an adequate trial, where the response is inadequate, in malabsorption or ongoing significant blood loss, and in certain chronic conditions such as inflammatory bowel disease or chronic kidney disease.
Clinically significant dehydration
When someone cannot keep fluids down or is dehydrated to a degree that oral rehydration cannot safely correct, intravenous fluids are the appropriate treatment — a medical decision, not a lifestyle one.
Specific prescribed indications
Some intravenous nutrient preparations are licensed medicines with defined indications, given under medical supervision for those indications rather than as general supplementation.
What is not on this list
Tiredness without a diagnosis, general wellness, hangovers, skin appearance and 'topping up' in the absence of a measured deficiency are not established indications. Where infusions are marketed for these, published supporting evidence is limited or absent. This matters because the intravenous route is not risk-free: even when an infusion is clinically indicated, it carries cannula-site complications, and less commonly allergic reaction, fluid or electrolyte disturbance and bloodstream infection. Those risks are worth accepting for a diagnosed problem and harder to justify without one.
Sources: NHS — Vitamin B12 or folate deficiency anaemia: Treatment; British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults (PMC)
IV drips vs oral supplements: side-by-side comparison
The table below sets out the practical differences between the two routes. It compares how each is given, who it suits, how quickly it acts, what can go wrong, and whether clinical assessment is required before treatment.
| Criteria | Oral supplements | IV drips |
|---|---|---|
| How it is given | Tablets, capsules or liquid taken at home; no equipment or supervision needed. | A cannula placed in a vein, with fluid infused over a period of time in a licensed clinical setting. |
| Who it suits | Most people with a normal digestive tract and a confirmed, non-severe deficiency. | People with malabsorption, altered gut anatomy, intolerance or failure of oral treatment, or a deficiency requiring rapid correction. |
| Onset | Gradual — stores are usually rebuilt over weeks to months, which is adequate for deficiencies that developed over the same timescale. | Blood levels rise during the infusion; whether that translates into a faster clinical improvement depends entirely on the condition being treated. |
| Risk profile | Low. Mainly gastrointestinal upset, and toxicity risk if fat-soluble vitamins or iron are taken in excess without indication. | Higher. Includes cannulation-related problems such as phlebitis, infiltration and bruising, and rarer systemic risks including allergic reaction, fluid or electrolyte disturbance and bloodstream infection. |
| Needs clinical assessment | Advisable — a doctor or pharmacist should confirm what is low and check for interactions. | Required. Prescription, medical assessment and administration by licensed healthcare professionals in a licensed facility. |
| Cost and time in principle | Lower cost per course; no appointment or travel time. | Higher cost per session because of consultation, prescription, staff time, sterile consumables and facility use, plus scheduled clinic time for each infusion. |
| Typical use case | Correcting and then maintaining a confirmed deficiency in an otherwise healthy adult. | Replacing a nutrient the gut cannot absorb, or treating a diagnosed condition where the intravenous route is the recommended one. |
How do the risks compare?
This is the part most comparisons leave out. Swallowing a tablet carries very little risk beyond stomach upset and the possibility of taking too much of something. Placing a cannula and infusing fluid into a vein introduces a set of risks that do not otherwise exist, however routine the procedure looks.
- Local complications at the cannula site: pain, bruising, phlebitis (inflammation of the vein) and infiltration, where fluid leaks into surrounding tissue. Systematic review data show these are common enough to be a routine consideration rather than a rarity.
- Infection: bloodstream infection from a peripheral cannula is uncommon, but it is a serious event and the reason sterile technique and a licensed setting are non-negotiable.
- Allergic and hypersensitivity reactions to an infused substance, which occur faster and are harder to interrupt than a reaction to something swallowed.
- Fluid and electrolyte disturbance, which matters particularly for anyone with heart or kidney disease.
- Excess intake of nutrients that accumulate — a risk shared with oral supplements, but reached more easily by infusion.
None of this means intravenous treatment is dangerous when properly indicated and properly administered; it means the risk is not zero, so there should be a reason for accepting it. Where a tablet would achieve the same outcome, the tablet is the lower-risk option.
Sources: Peripheral intravenous catheter infection and failure: a systematic review and meta-analysis (International Journal of Nursing Studies, PubMed); Phlebitis and infiltration: vascular trauma associated with the peripheral venous catheter (PubMed)
What is the practical decision path?
Test first, then treat what is actually low, by the simplest route that will work. Reversing that order — choosing an infusion and then looking for a reason to justify it — is how people end up paying for treatment of a deficiency they never had.
- 1
Describe the actual problem
Fatigue, breathlessness, hair changes and low mood have many possible causes, most of them not nutritional. Thyroid disease, sleep disorders, depression, anaemia from blood loss and undiagnosed chronic illness all present this way.
- 2
Get assessed and tested
A doctor takes a history, examines where necessary, and requests the relevant blood tests — commonly full blood count, ferritin, vitamin B12, folate and vitamin D, with others added according to the picture.
- 3
Interpret the results in context
A number below a laboratory range is a finding, not a diagnosis. The next question is why it is low, because the cause determines the treatment.
- 4
Choose the route on clinical grounds
Normal gut and a moderate deficiency: oral replacement. Malabsorption, intolerance, failed oral treatment or severe deficiency: intravenous replacement may be appropriate.
- 5
Retest and stop when corrected
Replacement should have an endpoint. Repeat testing shows whether it worked and prevents treatment continuing indefinitely without reason.
What can a blood test tell you — and what can it not?
Blood tests are the reason this decision can be made rationally rather than by marketing. They are also frequently over-interpreted. Knowing their limits is part of using them well.
What they can show
Whether a specific nutrient is below the reference range, whether anaemia is present and what type, and whether levels have responded to treatment on retesting.
What they cannot show
Why a level is low. A low ferritin may reflect diet, heavy menstrual bleeding, malabsorption or bleeding in the gut — and the last of these needs investigating rather than infusing.
Where results mislead
Ferritin rises with inflammation and can look normal despite genuine iron deficiency. Serum B12 does not always reflect what is happening inside cells. Results are interpreted alongside symptoms, not instead of them.
What a normal result means
That the nutrient tested is not the explanation. That is a useful finding: it redirects the search rather than ending it, and it is a reason not to treat.
Panels sold alongside treatment
Where testing and infusion are bundled as a single package, there is an inbuilt incentive for the result to point towards treatment. Testing is most useful when the decision about what to do next is genuinely open.
Sources: NIH Office of Dietary Supplements — Iron Fact Sheet for Health Professionals (serum ferritin is affected by inflammation); British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults (PMC); NIH Office of Dietary Supplements — Vitamin B12 Fact Sheet for Health Professionals
Where to start in Dubai
The starting point is a consultation with a doctor at a DHA-licensed facility, with blood tests requested on clinical grounds. Only after those results are available is the question of route — tablets or infusion — a meaningful one.
Intravenous nutrient treatment in Dubai is a medical service. It requires assessment and prescription by a licensed doctor and administration by licensed healthcare professionals in a licensed facility. Home-based intravenous services are additionally subject to Dubai's home healthcare licensing rules, which restrict that model to defined patient groups.
Any DHA-licensed clinic that tests before it treats, explains the limits of those tests, and is willing to say that no treatment is needed is a reasonable place to begin.
Questions worth asking before booking
Will I be assessed and tested before any infusion is recommended? Which doctor is prescribing, and what is their DHA licence? What exactly is in the infusion and what is it for? What are the risks and side effects? And what happens if the tests come back normal?
Frequently asked questions
Are IV drips better absorbed than tablets?
Intravenous delivery bypasses the digestive tract, so the substance enters the bloodstream directly. That is a real difference, but it is not a health benefit in itself. In someone whose gut absorbs normally and whose levels are not low, there is no established advantage. The fixed absorption percentages often quoted to contrast the two routes are not supportable, because bioavailability varies by nutrient, by dose and by the individual. The intravenous route also carries risks a tablet does not, including phlebitis, infiltration, allergic reaction and infection.
If I take a very high dose of vitamin C, do I absorb it all?
No. Absorption is saturable. Pharmacokinetic research in healthy volunteers found a single 200 mg dose was completely bioavailable, while at single doses of 500 mg and above bioavailability fell and the surplus was excreted in urine. Larger oral doses do not produce proportionally larger increases in plasma concentration.
Do I need injections for vitamin B12, or will tablets work?
It depends on why the level is low. Where the cause is dietary and absorption is intact, oral supplementation is generally appropriate. Where the cause is pernicious anaemia — an autoimmune loss of intrinsic factor — NHS guidance describes treatment with hydroxocobalamin injections, given as a loading course and then as long-term maintenance, because the malabsorption itself cannot be corrected. This is a decision for the treating doctor.
When is intravenous iron used instead of iron tablets?
Oral iron is first-line for most adults with iron deficiency anaemia. The intravenous route is used in defined situations: intolerance of oral iron after an adequate trial, inadequate response, malabsorption, ongoing significant blood loss, and certain chronic conditions including inflammatory bowel disease and chronic kidney disease. Any newly found iron deficiency also needs its cause investigated.
Is an IV drip riskier than taking a supplement?
Yes, in the sense that it introduces risks a tablet does not. Cannulation can cause pain, bruising, phlebitis and infiltration; less commonly there can be allergic reactions, fluid or electrolyte disturbance, and bloodstream infection. These risks are manageable in a licensed clinical setting, but they are a reason to use the intravenous route only where there is a clinical indication for it.
Should I get a blood test before considering an IV drip?
Testing before treatment is the sensible order. It establishes whether anything is actually low, which nutrient it is, and often points to why — and a normal result is a legitimate outcome that means no replacement is needed. Interpretation should be done by a doctor alongside symptoms and history, since results such as ferritin can be distorted by inflammation.
Where can I have this assessed in Dubai?
At any DHA-licensed clinic with a doctor who will assess, test and interpret results before recommending treatment. Intravenous nutrient treatment requires a prescription and must be administered by licensed healthcare professionals in a licensed facility.